Novo Nordisk's Cagri-Sema Evergreening The Franchise Part I Novo Nordisk, the leader in weight loss market, is going after tolerability instead of efficacy with this combination drug targeting GLP-1 and amylin
doi: 10.1016/j.ijbiomac.2025.14104 151 LukicI.GetselterD.KorenO.ElliottE
The outer layer imparts a hint of luscious color and protects lips, while the Vitamin C enriched core delivers antioxidant protection against environmental damage
Reduces dark spots, blemishes, and pigmentation issues
However, the challenge with current TRPV1 antagonists lies in their associated adverse effects, such as hyperthermia 24,25,26,27,28,29,30,31 and hypothermia 32,33,34 , caused by failures in thermoregulation
de Souza Santos V, Peters B, Cco LZ et al (2019) Silymarin protects against radiocontrast-induced nephropathy in mice